Feasibility of Catheter Cryoablation in Normal Ventricular Myocardium and Healed Myocardial Infarction

Lesion Formation in Cardiac Pulsed-Field Ablation: Acute to Chronic Cellular Level Changes

As pulsed-field ablation (PFA) emerges as a promising therapy for atrial arrhythmias, an understanding of the cellular injury to cardiac tissue is critical to evaluating and interpreting results for each PFA system. This review aims to detail the mechanism of cell death for PFA, compare the cell death mechanism to thermal ablation modalities, clarify common histology markers, detail the progression of PFA lesions from the acute, to subacute, to chronic maturation states, and discuss clinical indicators of PFA lesions.

Efficacy of balloon-expandable extreme-low-temperature ventricular epicardial cryoablation: A preclinical proof of concept evaluation

BACKGROUND

Current epicardial ablation technologies are limited by the inability to create adequate depth lesions and risk of collateral injury to extracardiac structures.

OBJECTIVE

The purpose of this study was to evaluate the feasibility and efficacy of ventricular epicardial ablation with a novel balloon-expandable extreme-low-temperature (XLT) cryoablation catheter with an embedded insulation pontoon for protection of extracardiac structures, which has been specifically designed for epicardial ablation.

METHODS

Ten healthy swine underwent surgical (n = 6) and subxiphoid percutaneous (n = 4) epicardial access. A total of 3-6 sites were targeted in the right and left ventricular wall for different exposure durations. Ablation was performed with a large footprint (surgical) and smaller footprint (percutaneous) version of the HeartPad (Corfigo Inc., Montclair, NJ) XLT system. The system consists of the balloon-expandable cryoablation catheter and a console. The console vaporizes liquid helium (-269°C) and controls continuous delivery of extremely cold helium gas at high flow rates through a high-efficiency ablation element mounted on an expandable insulation pontoon to protect extracardiac structures. Ablation lesions were assessed by gross pathology and histologic examination.

RESULTS

A total of 42 epicardial lesions were created. Mean lesion depth increased progressively with ablation time (surgical catheter: 11 ± 2 mm at ≤30 seconds, 13 ± 4 mm at 60 seconds, 15 ± 3 mm at ≥120 seconds, P = .001; percutaneous catheter: 10 ± 2 mm at 30 seconds, 14 ± 2 mm at 60 seconds, 16 ± 2 mm at 120 seconds, P = .001). Lesion geometry seemed unaffected by presence and thickness of epicardial fat. One episode of ventricular fibrillation occurred after ablation over the atrioventricular groove and 2 adjacent obtuse marginal arteries.

CONCLUSION

Surgical or percutaneous epicardial ablation using the HeartPad XLT cryoablation system is feasible and can efficiently produce deep ventricular lesions in different epicardial locations.

A simplified approach to radiofrequency catheter ablation of idiopathic ventricular outflow tract premature ventricular contractions

BACKGROUND

Frequently, low voltage areas (LVAs) and diastolic potentials (DPs) are present at ablation site in sinus rhythm in patients with idiopathic premature ventricular contractions (PVCs).

OBJECTIVE

Validate these findings as substrate for PVCs and evaluate the feasibility of a simplified substrate approach based on LVAs and DPs for ablation of idiopathic outflow tract PVCs, in patients with a low PVC burden during the procedure.

METHODS

Prospective single-arm clinical trial at two centers with comparison with a historical group, matched to age and gender. The study group consisted of consecutive patients referred for ablation of frequent idiopathic PVCs with inferior axis, that presented with less than 2 PVCs/min in first 5 minutes of the procedure. The ablation was based on fast mapping of the RVOT in sinus rhythm looking for LVAs and DPs, defined as isolated small amplitude potentials occurring after the T wave of the surface ECG. The area with LVAs and DPs was tagged, and a simplified activation mapping of the PVCs was done in that area. The procedure time, success rate and recurrence rate were compared with the historical group in whom ablation was performed based on activation and pace mapping only. A validation group without PVCs was also studied to assess the prevalence of LVAs and DPs in the general population.

RESULTS

The study (n=38), historical (n=38) and validation (n=38) groups did not differ in relation to age or gender. Prevalence of LVAs and DPs was significantly higher in the study group in comparison with the validation group, respectively, 71% vs 11%, p<0.0001 and 87% vs 8%, p<0.0001. Procedure time was significantly lower in the study group when comparing to the historical group, 130 (100-164) vs 183 (160-203) min, p<0.0001 and the success rate was significantly higher, 90% vs 64%, p=0.013. The recurrence rate in patients with a successful ablation was not significantly different between both groups, Log-Rank=0.125.

CONCLUSION

Prevalence of LVAs and DPs was significantly higher in the study group than in the validation group. The proposed approach proved to be feasible, faster and more efficient than the historical approach. This article is protected by copyright. All rights reserved.

Catheter-based cryoablation of postinfarction and idiopathic ventricular tachycardia: initial experience in a selected population

INTRODUCTION

Transvenous cryoablation has proven to be safe and effective for the treatment of supraventricular arrhythmias. The aim of this prospective study was to report the feasibility and safety of catheter-based cryoablation for the treatment of postinfarction and idiopathic ventricular tachycardia (VT).

METHODS AND RESULTS

Catheter-based cryoablation was performed in 17 patients (15 men, 58 +/- 18 years). VT occurred after a prior myocardial infarction in 10 and was idiopathic in 7 patients. Cryoablation was performed with a 10-F, 6.5-mm tipped catheter. The ablation site was selected using entrainment mapping techniques for postinfarction VT. The site of the earliest activation time with optimal pace mapping was used for ablation of idiopathic VT. All targeted VTs (12 postinfarction and 7 idiopathic) were acute successfully ablated after a median number of 2 applications of 5 minutes with an average temperature of -82 +/- 4 degrees C. Mean procedure and fluoroscopy times were 204 +/- 52 and 52 +/- 20 minutes for postinfarction VT and 203 +/- 24 and 38 +/- 15 minutes for idiopathic VT. No cryocatheter or cryoenergy complications were observed. After a follow-up of 6 months, 4 of the 10 patients with postinfarction VT had a recurrence. In 1 of the 7 patients with idiopathic VT the index arrhythmia recurred.

CONCLUSION

In this small patient population, catheter-based cryoablation of VT was safe and effective. Future studies are needed to evaluate the effect of cryothermy in a larger group of patients, especially those with postinfarction VT.

Time to Electrode Rewarming After Cryoablation Predicts Lesion Size

INTRODUCTION

There are no methods in clinical use to assess tissue cooling during catheter cryoablation. Cryoablation electrode temperature may be a poor predictor of lesion size. The purpose of this study was to determine whether the time necessary for the cryoablation electrode to cool to target temperature or to rewarm after cryoablation can predict lesion size.

METHODS AND RESULTS

Cryoablation was performed on live porcine left ventricle in a saline bath (37 degrees C) using 8-mm-tip catheter. Cryoablation was given for 300 seconds under all permutations of the following conditions: electrode orientation vertical or horizontal, contact pressure 6 or 20 g, superfusate flow over electrode-tissue interface at 0.2 or 0.4 m/s (N = 10 each condition set, total 80 experiments). The time intervals necessary to cool the electrode to the target temperature of -75 degrees C and to rewarm to + 30 degrees C after termination of cryoablation were recorded. Lesion volume was predicted best by the time necessary to rewarm the electrode to +30 degrees C (r2 = 0.65, P < 0.0001), followed by electrode temperature (r2 = 0.28, P < 0.0001) and time to cool the electrode to -75 degrees C (r2 = 0.24, P < 0.0001). Time to +30 degrees C and time to -75 degrees C were associated with superfusate flow rate, contact pressure, and electrode orientation (r2 = 0.80 and 0.61, respectively, both P < 0.0001). Superfusate flow rate, contact pressure, and orientation were also highly predictive of lesion volume (r2 = 0.93, P < 0.0001).

CONCLUSIONS

Time to cryoablation electrode rewarming is a better predictor of cryoablation lesion size than is electrode temperature. Time to cryoablation electrode rewarming reflects important determinants of cryoablation lesion formation--convective warming, contact pressure, and electrode orientation--that are not ascertainable during clinical ablation procedures.

Determinants of lesion sizes and tissue temperatures during catheter cryoablation

BACKGROUND

Factors which influence lesion size from catheter-based cryoablation have not been well described. This study describes factors which influence lesion size during catheter cryoablation.

METHODS AND RESULTS

Cryoablation was delivered to porcine left ventricular myocardium in a saline bath using 4- or 8-mm electrode catheters. Ablation was delivered with the electrodes either vertical or horizontal to the tissue and both with and without superfusate flow over the electrode. The effect of electrode contact pressure was tested. Lesion dimensions were measured. All experiments were duplicated to measure tissue temperatures at 1-, 2-, 3-, and 5-mm deep to the ablation electrode. The 8-mm electrode produced lower tissue temperatures and larger lesion volumes when compared with the 4-mm electrode (all P < 0.05). Superfusate flow slowed the rate of tissue cooling, markedly warmed tissue temperatures, and reduced lesion volume when compared with no flow conditions. By linear regression modeling, lesion sizes and tissue temperatures were related to the presence of superfusate flow, electrode orientation, contact pressure and electrode size, or catheter refrigerant flow rate (r2 for models = 0.90-0.96, all P < 0.001). Electrode temperature predicted lesion size or tissue temperatures only when analyzed independent of electrode size or refrigerant flow rate.

CONCLUSIONS

Lesion sizes and tissue temperatures during catheter cryoablation are related to convective warming, electrode orientation, electrode contact pressure, and any of the following: electrode size, catheter refrigerant flow rate or electrode temperature. However, electrode temperature may be a poor predictor of lesion size and tissue temperature for a given catheter size.

Transvenous radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia and its pitfalls: A rationale for cryoablation?

Today, radiofrequency (RF) catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT) is accompanied by a high success, a low recurrence, and a low complication rate. Despite the fact that over the years this technique has been refined, several shortcomings still remain. In this overview, the most important pitfalls in the treatment of AVNRT with RF energy are discussed. Cryotherapy has the ability to overcome some of them. Both ice mapping and cryo-adherence are important characteristics of this energy source to study prospective ablation sites before a definitive and irreversible lesion is created. Theoretically, this could lead to less applications with less tissue damage and abolish the risk for permanent conduction disturbances. The early experience with this technique will be described. Until now, it still has to be proven that in a large cohort of patients, cryotherapy is at least as effective, and safer than RF.